f it weren’t for the “Giant 5,” your money would have been better off in a savings account than the stock market over the past few years, according to Wolf Richter of the Wolf Street blog.
An alliance of crude producers led by Saudi Arabia is pushing OPEC and its allies to increase oil production starting in August, officials in the group said, amid signs that demand is returning to normal levels following coronavirus-related lockdowns.
House Speaker Nancy Pelosi said Thursday she was unconvinced of the need to limit eligibility for another round of coronavirus economic aid checks to people making less than $40,000 annually, an idea that’s been broached by a top Republican.
Whether you want small or big, 2- row or 3-row, hybrid or conventional, a $40,000 budget can go a long way.
Several of the U.K.’s leading grocers have vowed never to sell chlorine-washed chicken and hormone-injected beef as the U.K. negotiates a free-trade agreement with th U.S.
Wearing a mask has become a uniquely hot-button issue in the U.S., which finds itself in the throes of viral pandemic that appears to be drifting out of control by the day.
The holiday weekend has done nothing to slow the positive momentum for U.S. stocks, with futures significantly higher on Monday
The Democratic strategist predicts Republican Senators like Mitch McConnell and Lindsey Graham will turn on Trump after Labor Day
‘Now we’re seeing the consequence of community spread,’ said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
There will be very little useful guidance from U.S. corporations in the earnings reporting season starting mid-July on what the rest of 2020 will look like for the stock market and analysts are very divided on the outlook
Brokerages make money by allowing companies called ‘market makers’ to act as middlemen between parties that want to buy and those that want to sell. It’s not nefarious, one long-time industry veteran notes, it’s how financial markets work – and work better.
Flare ups of COVID-19 cases in the U.S. are delivering a fresh gut check to Wall Street’s bullish demeanor, since its unprecedented rebound from a coronavirus-ignited downturn back in March.
Big shares of a losing biotech stock didn’t stop a pair of four-star-rated ETFs from moving higher Thursday. They may sound similar, but hold distinct investments once you look under the hood.
European stocks pushed higher on Friday and were headed for a weekly gain after days of worries over rising coronavirus cases in parts of the world. Potential good news on the U.S.-China trade front was inspiring some gains.
London stocks were set to end the week on a high note on Friday, as appetite for risk among investors helped boost global equities and oil prices, which in turn triggered gains for heavily-weighed energy companies.
Foreaders 